Stock 300363 PORTON PHARMA SOLUTIONS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Porton Pharma Solutions Ltd.

Equities

300363

CNE100001S57

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
16.81 CNY -1.70% Intraday chart for Porton Pharma Solutions Ltd. -1.00% -33.16%
04-26 Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-26 Porton Pharma Solutions Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.

Number of employees: 4,915

Sales per Business

CNY in Million2022Weight2023Weight Delta
Late Clinical and Commercialization
78.3 %
6,282 89.3 % 2,873 78.3 % -54.27%
Early Clinical
17.6 %
613 8.7 % 645 17.6 % +5.10%
Others
4.1 %
139 2.0 % 150 4.1 % +7.63%

Sales per region

CNY in Million2022Weight2023Weight Delta
Overseas
76.7 %
6,322 89.9 % 2,812 76.7 % -55.52%
China
23.3 %
713 10.1 % 855 23.3 % +20.02%

Managers

Managers TitleAgeSince
Nian Feng Ju CEO
 Chief Executive Officer 52 10-12-31
Hui Chen DFI
 Director of Finance/CFO 45 22-04-21
Yong Qing Tan CHM
 Chairman 69 19-04-15
Hui Zeng BRD
 Director/Board Member 44 10-12-31
Xing Xing Wang IRC
 Investor Relations Contact 36 20-10-25
Wei Pi HRO
 Human Resources Officer 37 -
Po Zhu PRN
 Corporate Officer/Principal 54 10-12-29

Members of the board

Members of the board TitleAgeSince
Wei Gang Yuan BRD
 Director/Board Member 57 21-08-04
Nian Feng Ju CEO
 Chief Executive Officer 52 10-12-31
Hui Zeng BRD
 Director/Board Member 44 10-12-31
Guo Hua Cao BRD
 Director/Board Member 57 20-09-27
Lin Yuan BRD
 Director/Board Member 60 22-04-17
Yong Qing Tan CHM
 Chairman 69 19-04-15
Jin Wei Pang BRD
 Director/Board Member 56 22-04-17
Guo Jun Cao BRD
 Director/Board Member 59 22-04-17
Li Na Hu BRD
 Director/Board Member 65 22-04-17
Yu Chen Wu BRD
 Director/Board Member 32 22-04-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 546,037,820 310,763,341 ( 56.91 %) 7,856,444 ( 1.439 %) 56.91 %

Shareholders

NameEquities%Valuation
Chongqing Liangjiang New Area Industrial Development Group
15.80 %
78,982,719 15.80 % 196 M ¥
Rong Tao
8.848 %
44,218,630 8.848 % 110 M ¥
He Bing Zhang
8.385 %
41,903,020 8.385 % 104 M ¥
Zhong Ou Asset Management Co., Ltd
3.351 %
16,747,738 3.351 % 41 M ¥
Nian Feng Ju
2.946 %
14,722,630 2.946 % 36 M ¥
Hwabao WP Fund Management Co., Ltd.
1.697 %
8,482,060 1.697 % 21 M ¥
Zhangjiagang Zhuoyuan Investment Ptp LP
1.597 %
7,982,347 1.597 % 20 M ¥
China Merchants Fund Management Co., Ltd.
1.319 %
6,591,651 1.319 % 16 M ¥
GF Fund Management Co., Ltd.
1.286 %
6,427,677 1.286 % 16 M ¥
E Fund Management Co., Ltd.
0.8889 %
4,442,400 0.8889 % 11 M ¥
NameEquities%Valuation
Nian Feng Ju
95.44 %
44,167,891 95.44 % 109 M ¥

Company contact information

Porton Pharma Solutions Ltd.

7 Yuntu Road Beibei District

400714, Chongqing

+

http://www.porton.cn
address Porton Pharma Solutions Ltd.(300363)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Porton Pharma Solutions Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
16.81 CNY
Average target price
26.65 CNY
Spread / Average Target
+58.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
PORTON PHARMA SOLUTIONS LTD. Stock Porton Pharma Solutions Ltd.
-33.16% 1.27B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300363 Stock
  4. Company Porton Pharma Solutions Ltd.